Not Evaluable News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Not Evaluable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Not Evaluable Today - Breaking & Trending Today

Janssen Presents Longer-Term Data for TECVAYLI® (teclistamab-cqyv) Showing a Duration of Response of 22 Months in Patients with Relapsed or Refractory Multiple Myeloma

Published: June 5, 2023

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today long-term data from the pivotal Phase 1/2 MajesTEC-1 study showing...

Source: prnewswire.com

Related Topics:

Noord HollandUnited StatesRachel KobosSatu GlaweChristie CorbettEastern Cooperative Oncology GroupExchange CommissionNone Of The Janssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonEuropean Medicines AgencyJanssen Pharmaceutical CompaniesEuropean CommissionAmerican Cancer SocietyAmerican Society Of Clinical OncologyNational Comprehensive Cancer NetworkJanssen Research DevelopmentCompanies Of JohnsonInternational Myeloma Working GroupJanssen Oncology Research DevelopmentOther Administration ReactionsNational Cancer InstituteClinical OncologyAnnual MeetingConfidence IntervalNot Evaluable